Clin2
NCT07764965Possibly a fitNot yet recruiting

Eye drop safety study in healthy adults

Wet Age Related Macular DegenerationNeovascular (Wet) Age-Related Macular Degeneration

Part of Eyes & vision clinical trials.

This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You must be between 18 and 50 years old.
  • You must be in good general health, with no major medical conditions.
  • Your body weight and body mass index must be within a specific range.
  • You must have good vision in at least one eye (20/25 or better).
  • You cannot be pregnant, breastfeeding, or planning a pregnancy during the study, and you must use effective birth control.
  • You must not have active eye problems, eye surgery, or wear contact lenses during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07587515Recruiting· Phase 1/Phase 2
New Eye Drop Treatment for Wet Age-Related Macular Degeneration

This study tests a new experimental eye drop (EYC-0305) for wet AMD, a common cause of vision loss in older adults. The goal is to see if it can slow or prevent further damage to central vision.

Beverly Hills, California
NCT07313722Recruiting· Phase 1
Testing a new eye drop for safety in healthy volunteers

This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.

Shanghai
NCT07370584Recruiting· Phase 1
Safety study of IVMED-85 eye drops in healthy adults

This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.

Memphis, Tennessee
NCT06832657Not yet recruiting· Phase 1
Testing a new eye drop in healthy adults

This trial tests a new eye drop called JMKX003948 in healthy volunteers. It checks if the eye drop is safe and how the body handles it.

NCT06379685Not yet recruiting· Phase 1
Testing new eye drops for safety and comfort

This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.

NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

Hear when a new Wet Age-related Macular Degeneration trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.